ALLO — ALLOGENE THERAPEUTICS INC

Ownership history in TPG GP A, LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which TPG GP A, LLC reported a position in ALLOGENE THERAPEUTICS INC (ALLO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.31% (2022 Q3)
Avg. % of fund
1.57%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 18,716,306 — 0% 0.95% $25.6M $1.37
2025 Q3 UNCHANGED 18,716,306 — 0% 1.26% $23.2M $1.24
2025 Q2 UNCHANGED 18,716,306 — 0% 1.13% $21.1M $1.13
2025 Q1 UNCHANGED 18,716,306 — 0% 0.54% $27.3M $1.46
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ALLO price (monthly, adj. close)

Other funds also holding ALLO

As of 2025 Q4 — sorted by position size

PFIZER INC 12.76% Wildcat Capital Management, LLC 3Y 7Y 2.93% Patient Square Capital LP 3Y 1.46% DAFNA Capital Management LLC 3Y 7Y 0.44% Frazier Life Sciences Management, L.P. 3Y 0.14% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.07% Virtus Investment Advisers, LLC 3Y 7Y 0.07% Woodline Partners LP 3Y 0.02% XTX Topco Ltd 3Y 0.02% Navalign, LLC 3Y 0.02%
← Back to TPG GP A, LLC Holdings